SCHEMBL6553826

SCHEMBL6553826

COC(=O)/C=C(/C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.48
NOTUM Q6P988 1/20 0.47
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
P2RX1 P51575 2/20 0.39
GPR35 Q9HC97 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
RHOC P08134 1/20 0.37
RHOA P61586 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553829 1.00 CES2 (0.48) CES2NOTUMNR4A1NR4A2NR4A3
SCHEMBL7961166 0.84 NPSR1 (0.55) CES2GAAMAPTALDH1A1LMNA
SCHEMBL7961170 0.84 NPSR1 (0.55) CES2GAAMAPTALDH1A1LMNA
SCHEMBL8047986 0.83 NR4A1 (0.68) CES2NR4A1NR4A2NR4A3MAPT
SCHEMBL6554660 0.75 TPMT (0.43) MAPTALDH1A1SMN1; SMN2
SCHEMBL6554658 0.75 TPMT (0.43) MAPTALDH1A1SMN1; SMN2
SCHEMBL1999038 0.74 NOTUM (0.77) CES2NOTUMGAAMAPTALDH1A1
SCHEMBL5779119 0.74 CES2 (0.44) CES2NOTUMGAAMAPTALDH1A1
SCHEMBL96116 0.72 CES2 (0.67) CES2NOTUMGAAMAPTP2RX1
SCHEMBL6553777 0.72 CES2 (0.50) CES2NOTUMNR4A1NR4A2NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149067-B1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS HOFFMANN LA ROCHE (CH) 2004-02-25 EP disclosed
EP-1149067-A1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
US-6310247-B1 HAS APOPTOTIC ACTIVITY USEFUL FOR PROPHYLAXIS AND THERAPY OF CANCER HOFFMANN-LA ROCHE INC. 2001-10-30 US disclosed
WO-2000035856-A1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed